Belviq Xr
NDC Package 62856-535-30

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Belviq Xr is lorcaserin is used with a doctor-approved exercise, behavior change, and reduced-calorie diet program to help you lose weight. Marketed by Eisai Inc., this product is identified by NDC 62856-535 and is authorized under FDA application NDA208524.

Identification & Billing

NDC Package Code
62856-535-30
Package Description
30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE
Product Code
62856-535
11-Digit Billing Format
62856053530
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
30 EA

Clinical Specifications

Proprietary Name
Belviq Xr
Dosage Form
-
Usage Information
Lorcaserin is used with a doctor-approved exercise, behavior change, and reduced-calorie diet program to help you lose weight. It is used by certain overweight people, such as those who are obese or have weight-related medical problems. Losing weight and keeping it off can lessen the many health risks that come with obesity, including heart disease, diabetes, high blood pressure, and a shorter life. Lorcaserin belongs to a class of drugs known as serotonin receptor agonists. It is thought to work by affecting a certain part of the brain that helps control your appetite. This drug has been withdrawn from the US market due to problems with safety.

Regulatory & Marketing

Labeler Name
Eisai Inc.
FDA Application #
NDA208524
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
07-15-2016
End Marketing Date
05-31-2022
Listing Expiration
05-31-2022
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 62856-535-30 identifies a specific commercial package of 30 tablet, film coated, extended release in 1 bottle of Belviq Xr, labeled by Eisai Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Eisai Inc. on July 15, 2016. The current certification is valid through May 31, 2022.

What are the primary indications for this medication?

Lorcaserin is used with a doctor-approved exercise, behavior change, and reduced-calorie diet program to help you lose weight. It is used by certain overweight people, such as those who are obese or have weight-related medical problems. Losing weight and keeping it off can lessen the many health risks that come with obesity, including heart disease, diabetes, high blood pressure, and a shorter life. Lorcaserin belongs to a class of drugs known as serotonin receptor agonists. It is thought to work by affecting a certain part of the brain that helps control your appetite. This drug has been withdrawn from the US market due to problems with safety.

How is this Eisai Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 62856053530. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
62856-535-30
11-Digit CMS (5-4-2)
62856-0535-30

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.